AU3603893A - Autoantibody assay and usage in the control of human disease - Google Patents

Autoantibody assay and usage in the control of human disease

Info

Publication number
AU3603893A
AU3603893A AU36038/93A AU3603893A AU3603893A AU 3603893 A AU3603893 A AU 3603893A AU 36038/93 A AU36038/93 A AU 36038/93A AU 3603893 A AU3603893 A AU 3603893A AU 3603893 A AU3603893 A AU 3603893A
Authority
AU
Australia
Prior art keywords
usage
control
human disease
autoantibody assay
autoantibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36038/93A
Inventor
Robert Perper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3603893A publication Critical patent/AU3603893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU36038/93A 1992-02-12 1993-02-01 Autoantibody assay and usage in the control of human disease Abandoned AU3603893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83569692A 1992-02-12 1992-02-12
US835696 1992-02-12

Publications (1)

Publication Number Publication Date
AU3603893A true AU3603893A (en) 1993-09-03

Family

ID=25270231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36038/93A Abandoned AU3603893A (en) 1992-02-12 1993-02-01 Autoantibody assay and usage in the control of human disease

Country Status (5)

Country Link
EP (1) EP0625909A4 (en)
JP (1) JPH07504495A (en)
AU (1) AU3603893A (en)
CA (1) CA2129895A1 (en)
WO (1) WO1993015759A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay

Also Published As

Publication number Publication date
EP0625909A4 (en) 1997-03-05
CA2129895A1 (en) 1993-08-13
EP0625909A1 (en) 1994-11-30
JPH07504495A (en) 1995-05-18
WO1993015759A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
GB9214857D0 (en) Human nucleic acid fragments and their use
AU673703B2 (en) Injector and use of the same
AU628511B2 (en) Emulsifier-free hand and body lotion
HU9602104D0 (en) Novel medicines and their use
EP0768038A3 (en) Shortening and its use
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU7992994A (en) Immunoassay for the dectection of human autoantibodies
AU4514093A (en) Recombinant antibody against human interleukin-1
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use
AU6761294A (en) Cell surface protein expressed on human cortical thymocyte and their use
AU5737494A (en) Human thrombospondin-4
AU1163592A (en) Highly sensitive assay of tissue factor and kit therefor
AU631448B2 (en) Application aid and the use thereof
AU4118393A (en) Human crabp-I and crabp-II
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU7260098A (en) Diagnosis and treatment of phosphatase 0r kinase-related disorders
AU5293198A (en) Promoter of the human endoglin gene and its use
GB9514816D0 (en) Substances and their medical use
EP0744125A3 (en) Iodo-complex and its use
AUPN024994A0 (en) Assay and peptides for use therein
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
AU3603893A (en) Autoantibody assay and usage in the control of human disease
GB2279956B (en) Recombinant human and rat AMP-protein kinases
EP0863204A4 (en) Human cyclin i and gene encoding the same
AU5447194A (en) Diagnostic reagents and their use in the detection of human herpesvirus 7